insight
Nature 429, 469-474 (27 May 2004) | doi:10.1038/nature02627
Oncogenomics and the development of new cancer therapies
Robert L. Strausberg1, Andrew J.G. Simpson2, Lloyd J. Old2 and Gregory J. Riggins3
Abstract
Scientists have sequenced the human genome and identified most of its genes. Now it is time to use these genomic data, and the high-throughput technology developed to generate them, to tackle major health problems such as cancer. To accelerate our understanding of this disease and to produce targeted therapies, further basic mutational and functional genomic information is required. A systematic and coordinated approach, with the results freely available, should speed up progress. This will best be accomplished through an international academic and pharmaceutical oncogenomics initiative.
- Department of Mammalian Genomics, The Institute for Genomic Research, 9712 Medical Center Drive, Rockville, Maryland 2085, USA Email: RLS@tigr.org
- Ludwig Institute for Cancer Research, 605 Third Avenue, New York, New York 10158, USA
- Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
HTTP Status 500 -
type Exception report
message
description The server encountered an internal error () that prevented it from fulfilling this request.
exception
javax.servlet.ServletException: Servlet execution threw an exception
root cause
java.lang.OutOfMemoryError
note The full stack trace of the root cause is available in the Tomcat logs.